Enoxaparin more effective and safer than unfractionated heparin for ACS/AMI

In this large meta-analysis of randomized controlled trials, enoxaparin use with ACS/AMI was associated with lower mortality and lower bleeding risk, compared to unfractionated heparin. The use of unfractionated heparin should continue to wane for many clinical conditions where enoxaparin is more effective and safer (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment